✦ LIBER ✦

Differences in Clinical Outcomes in Patients with Vancomycin-Resistant Enterococci According to Linezolid Susceptibility

✍ Scribed by Dr. Marc H. Scheetz; Dr. Stephanie A. Knechtel; Mr. Michael J. Postelnick; Mr. Michael Malczynski; Dr. Chao Qi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical impact of linezolid suscept

✍ Marc H. Scheetz; Chao Qi; Gary A. Noskin; John R. Warren; Michael J. Postelnick; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Linezolid and quinupristin/dalfopristin

✍ Mehmet Baysallar; Abdullah Kilic; Hakan Aydogan; Feriha Cilli; Levent Doganci 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Bacteremia due to Escherichia coli versu

✍ Dong-Gun Lee; Su Mi Choi; Jung-Hyun Choi; Jin-Hong Yoo; Wan-Shik Shin; Chun-Choo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Corrigendum to “Linezolid and quinuprist

✍ Mehmet Baysallar; Abdullah Kilic; Hakan Aydogan; Feriha Cilli; Levent Doganci 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 29 KB

Implications of colonization of vancomyc

✍ H. Humphreys; V. Dolan; T. Sexton; P. Conlon; L. Rajan; E. Creamer; J. Walshe; J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Comorbidity and clinical features in eld

✍ F. Formiga; I. Fort; M. J. Robles; S. Riu; O. Sabartes; E. Barranco; J. Catena 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 101 KB